Sellas Historical Income Statement

SLS Stock

USD 1.16 0.02 1.69%

Historical analysis of Sellas Life income statement accounts such as Depreciation And Amortization of 45.7 M, Selling General Administrative of 12.6 M, Selling And Marketing Expenses of 2.2 M or Gross Profit of 0.0 can show how well Sellas Life Sciences performed in making a profits. Evaluating Sellas Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sellas Life's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Sellas Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sellas Life Sciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Sellas Income Statement Analysis

Sellas Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sellas Life shareholders. The income statement also shows Sellas investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Sellas Life Income Statement Chart

At this time, Sellas Life's Interest Expense is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 45.7 M in 2025, whereas Operating Income is likely to drop (33.1 M) in 2025.

Other Operating Expenses Research Development Selling General Administrative Selling And Marketing Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sellas Life Sciences. It is also known as Sellas Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Sellas Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sellas Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Sellas Life income statement Correlations

	Interest Expense	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Net Income	Depreciation And Amortization	Selling General Administrative	Selling And Marketing Expenses	Gross Profit	Cost Of Revenue	Total Other Income Expense Net	Income Tax Expense	Total Revenue	Net Income From Continuing Ops	Non Operating Income Net Other	Discontinued Operations	Tax Provision	Interest Income	Extraordinary Items	Net Interest Income
Interest Expense		0.29	-0.21	-0.28	0.36	-0.3	0.29	0.11	0.02	-0.08	0.17	0.18	0.44	-0.27	0.3	0.1	0.48	0.14	0.23	-0.12	-0.04	0.21	-0.04	0.02
Other Operating Expenses	0.29		-0.95	-0.63	0.9	-0.54	0.84	-0.56	-0.54	0.21	0.82	0.59	0.57	-0.4	0.06	-0.39	0.55	-0.51	0.01	-0.09	-0.05	0.21	0.22	0.07
Operating Income	-0.21	-0.95		0.66	-0.91	0.56	-0.86	0.6	0.61	-0.22	-0.8	-0.58	-0.54	0.43	-0.03	0.37	-0.42	0.55	0.01	0.17	0.07	-0.24	-0.11	-0.09
Ebit	-0.28	-0.63	0.66		-0.52	0.81	-0.56	-0.16	-0.08	-0.18	-0.61	-0.37	-0.24	0.15	-0.69	0.37	-0.28	-0.23	-0.69	0.12	0.09	-0.44	-0.12	-0.01
Research Development	0.36	0.9	-0.91	-0.52		-0.45	0.81	-0.59	-0.63	0.13	0.57	0.51	0.52	-0.39	-0.02	-0.26	0.44	-0.55	-0.08	-0.23	-0.09	0.19	0.05	0.04
Ebitda	-0.3	-0.54	0.56	0.81	-0.45		-0.69	-0.09	0.01	0.0	-0.5	-0.23	-0.15	0.01	-0.41	0.13	-0.34	-0.13	-0.53	0.05	0.01	-0.43	-0.16	0.24
Total Operating Expenses	0.29	0.84	-0.86	-0.56	0.81	-0.69		-0.52	-0.53	0.13	0.68	0.37	0.41	-0.23	-0.11	-0.28	0.51	-0.49	0.0	-0.06	-0.01	0.32	0.06	-0.1
Income Before Tax	0.11	-0.56	0.6	-0.16	-0.59	-0.09	-0.52		0.93	-0.12	-0.4	-0.4	-0.46	0.43	0.75	0.12	-0.21	0.99	0.79	0.05	-0.06	0.04	-0.06	0.03
Net Income	0.02	-0.54	0.61	-0.08	-0.63	0.01	-0.53	0.93		-0.04	-0.34	-0.39	-0.43	0.45	0.65	0.03	-0.13	0.92	0.69	0.35	-0.16	-0.1	0.0	0.19
Depreciation And Amortization	-0.08	0.21	-0.22	-0.18	0.13	0.0	0.13	-0.12	-0.04		0.06	0.18	0.07	-0.21	-0.02	-0.93	-0.25	-0.12	0.01	0.0	-0.1	0.2	0.79	0.58
Selling General Administrative	0.17	0.82	-0.8	-0.61	0.57	-0.5	0.68	-0.4	-0.34	0.06		0.36	0.58	-0.35	0.15	-0.25	0.64	-0.37	0.12	0.08	0.01	0.1	0.01	0.0
Selling And Marketing Expenses	0.18	0.59	-0.58	-0.37	0.51	-0.23	0.37	-0.4	-0.39	0.18	0.36		0.41	-0.42	0.01	-0.2	0.11	-0.28	-0.18	-0.21	-0.18	0.06	0.23	0.3
Gross Profit	0.44	0.57	-0.54	-0.24	0.52	-0.15	0.41	-0.46	-0.43	0.07	0.58	0.41		-0.91	-0.09	-0.02	0.54	-0.41	-0.21	-0.19	-0.19	-0.11	0.04	0.28
Cost Of Revenue	-0.27	-0.4	0.43	0.15	-0.39	0.01	-0.23	0.43	0.45	-0.21	-0.35	-0.42	-0.91		0.13	0.06	-0.13	0.39	0.26	0.35	0.28	0.0	-0.14	-0.43
Total Other Income Expense Net	0.3	0.06	-0.03	-0.69	-0.02	-0.41	-0.11	0.75	0.65	-0.02	0.15	0.01	-0.09	0.13		-0.1	0.06	0.78	0.94	-0.09	-0.12	0.17	-0.01	0.12
Income Tax Expense	0.1	-0.39	0.37	0.37	-0.26	0.13	-0.28	0.12	0.03	-0.93	-0.25	-0.2	-0.02	0.06	-0.1		0.06	0.11	-0.14	-0.11	0.01	-0.25	-0.68	-0.42
Total Revenue	0.48	0.55	-0.42	-0.28	0.44	-0.34	0.51	-0.21	-0.13	-0.25	0.64	0.11	0.54	-0.13	0.06	0.06		-0.2	0.03	0.25	0.1	-0.26	-0.18	-0.19
Net Income From Continuing Ops	0.14	-0.51	0.55	-0.23	-0.55	-0.13	-0.49	0.99	0.92	-0.12	-0.37	-0.28	-0.41	0.39	0.78	0.11	-0.2		0.8	0.02	-0.11	0.03	-0.05	0.07
Non Operating Income Net Other	0.23	0.01	0.01	-0.69	-0.08	-0.53	0.0	0.79	0.69	0.01	0.12	-0.18	-0.21	0.26	0.94	-0.14	0.03	0.8		-0.04	-0.05	0.29	0.01	0.03
Discontinued Operations	-0.12	-0.09	0.17	0.12	-0.23	0.05	-0.06	0.05	0.35	0.0	0.08	-0.21	-0.19	0.35	-0.09	-0.11	0.25	0.02	-0.04		0.09	0.02	0.04	-0.11
Tax Provision	-0.04	-0.05	0.07	0.09	-0.09	0.01	-0.01	-0.06	-0.16	-0.1	0.01	-0.18	-0.19	0.28	-0.12	0.01	0.1	-0.11	-0.05	0.09		0.29	-0.05	-0.55
Interest Income	0.21	0.21	-0.24	-0.44	0.19	-0.43	0.32	0.04	-0.1	0.2	0.1	0.06	-0.11	0.0	0.17	-0.25	-0.26	0.03	0.29	0.02	0.29		0.17	-0.33
Extraordinary Items	-0.04	0.22	-0.11	-0.12	0.05	-0.16	0.06	-0.06	0.0	0.79	0.01	0.23	0.04	-0.14	-0.01	-0.68	-0.18	-0.05	0.01	0.04	-0.05	0.17		0.4
Net Interest Income	0.02	0.07	-0.09	-0.01	0.04	0.24	-0.1	0.03	0.19	0.58	0.0	0.3	0.28	-0.43	0.12	-0.42	-0.19	0.07	0.03	-0.11	-0.55	-0.33	0.4

Click cells to compare fundamentals

Sellas Life Account Relationship Matchups

Sellas Life income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	118K	390K	4.4M	649K	746.4K	806.9K
Other Operating Expenses	18.9M	32.9M	43.0M	37.9M	43.5M	28.8M
Operating Income	(17.0M)	(25.3M)	(42.0M)	(37.9M)	(31.5M)	(33.1M)
Ebit	(16.8M)	(20.9M)	(32.4M)	(37.3M)	(33.6M)	(35.3M)
Research Development	9.3M	21.4M	30.3M	24.0M	19.1M	16.6M
Ebitda	26.5M	(19.7M)	(32.0M)	529K	(31.5M)	(33.1M)
Total Operating Expenses	(18.9M)	32.7M	42.9M	37.9M	31.5M	26.7M
Income Before Tax	(16.8M)	(20.9M)	(41.3M)	(37.3M)	(30.9M)	(32.4M)
Net Income	(16.8M)	(20.7M)	(40.7M)	(37.3M)	(30.9M)	(32.4M)
Depreciation And Amortization	282K	1.3M	457K	37.9M	43.5M	45.7M
Selling General Administrative	9.6M	11.3M	12.6M	13.9M	12.4M	12.6M
Total Other Income Expense Net	17.0M	4.4M	649K	529K	632K	600.4K
Income Tax Expense	(17K)	(237K)	(649K)	(37.9M)	(34.1M)	(32.4M)
Net Income From Continuing Ops	(16.8M)	(20.7M)	(41.3M)	(38.3M)	(30.9M)	(32.4M)
Net Income Applicable To Common Shares	(28.0M)	(16.8M)	(20.7M)	(41.3M)	(47.5M)	(49.9M)
Interest Income	26K	6K	317K	642K	632K	323.0K
Net Interest Income	26K	6K	317K	642K	632K	663.6K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sellas Historical Income Statement

About Sellas Income Statement Analysis

Sellas Life Income Statement Chart

Other Operating Expenses

Sellas Life income statement Correlations

Sellas Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sellas Life income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Sellas Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income From Continuing Ops	+ 0.99	Income Before Tax
Non Operating Income Net Other	+ 0.94	Total Other Income Expense Net
Net Income	+ 0.93	Income Before Tax
Net Income From Continuing Ops	+ 0.92	Net Income
Research Development	+ 0.9	Other Operating Expenses
Total Operating Expenses	+ 0.84	Other Operating Expenses

Operating Income	- 0.95	Other Operating Expenses
Income Tax Expense	- 0.93	Depreciation And Amortization
Cost Of Revenue	- 0.91	Gross Profit
Research Development	- 0.91	Operating Income
Total Operating Expenses	- 0.86	Operating Income
Selling General Administrative	- 0.8	Operating Income